WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001025230) PROCESS FOR THE PREPARATION OF PAROXETINE HYDROCHLORIDE ACETONE SOLVATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/025230    International Application No.:    PCT/GB2000/003795
Publication Date: 12.04.2001 International Filing Date: 04.10.2000
Chapter 2 Demand Filed:    02.05.2001    
IPC:
A61K 31/4525 (2006.01), C07D 405/12 (2006.01)
Applicants: SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court, Brentford, Middlesex TW8 9EP (GB) (For All Designated States Except US).
CRAIG, Andrew, Simon [GB/GB]; (GB) (For US Only)
Inventors: CRAIG, Andrew, Simon; (GB)
Agent: WEST, Vivien; SmithKline Beecham, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB).
GIDDINGS, Peter john; GlaxoSmithKline, Corporate Intellectual Property, Two New Horizons Court, Brentford, Middlesex TW8 9EP, United Kingdom (GB)
Priority Data:
9923445.2 04.10.1999 GB
Title (EN) PROCESS FOR THE PREPARATION OF PAROXETINE HYDROCHLORIDE ACETONE SOLVATE
(FR) PROCEDE DE PREPARATION DE SOLVATE ACETONIQUE D'HYDROCHLORURE DE PAROXETINE
Abstract: front page image
(EN)A process for preparing paroxetine hydrochloride acetone solvate, in which a solution of paroxetine base, or a salt of paroxetine with an organic acid, is treated with acetone and a solution of hydrogen chloride in a carrier solvent, and paroxetine hydrochloride acetone solvate is isolated as a crystalline solid.
(FR)L'invention concerne un procédé de préparation de solvate acétonique d'hydrochlorure de paroxétine. Selon ce procédé, une solution à base de paroxétine ou un sel de paroxétine pourvu d'un acide organique est traité avec de l'acétone et avec une solution de chlorure d'hydrogène dans un solvant de support, puis le solvate acétonique d'hydrochlorure de paroxétine est isolé comme solide cristallin.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)